InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,230.01
(
-0.06%
)
Post# of 251939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: Rocky3 post# 188216

Thursday, 03/05/2015 5:53:17 PM

Thursday, March 05, 2015 5:53:17 PM

Post# of 251939
Barclay Propriety Rx Numbers from Mar 4, 2015:

Proprietary New Treatment Start data from AlphaImpactRx shows that Harvoni has a dominant 63% share across all patient genotypes, with Viekira Pak having captured a 15% share.

------

Harvoni captured 68-75% of Genotype 1 patients versus 14-21% for Viekira Pak during the last 3 weeks in January.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up